Skip to main content
Figure 2 | Virology Journal

Figure 2

From: Oral administration of interferon-α2b-transformed Bifidobacterium longum protects BALB/c mice against coxsackievirus B3-induced myocarditis

Figure 2

Pathological areas of the heart. The percentage of pathological areas in different groups was shown in (a). The coxsackievirus B3 (CVB3) titration detected by standard plaque formation assay was indicated in (b). The levels of interferon (IFN)-γ and tumor necrosis factor (TNF)-α mRNA were determined in (c) and (d) respectively. The concentration of, IFN-γ and TNF-α and were shown in (e, f and g) respectively. The detection of IFN-induced Mx1 mRNA was determined in (h). **versus B group, p > 0.05; *versus BIFN group, p < 0.01.

Back to article page